Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.35 - $2.87 $502,713 - $1.07 Million
-372,380 Reduced 60.29%
245,308 $360,000
Q2 2023

Aug 14, 2023

BUY
$1.33 - $2.51 $101,129 - $190,852
76,037 Added 14.04%
617,688 $1.55 Million
Q1 2023

May 15, 2023

BUY
$1.35 - $2.87 $18,924 - $40,231
14,018 Added 2.66%
541,651 $807,000
Q4 2022

Feb 14, 2023

SELL
$1.13 - $10.8 $193,570 - $1.85 Million
-171,301 Reduced 24.51%
527,633 $738,000
Q3 2022

Nov 14, 2022

BUY
$3.0 - $5.49 $267,507 - $489,537
89,169 Added 14.62%
698,934 $2.21 Million
Q2 2022

Aug 15, 2022

BUY
$3.13 - $12.25 $1.47 Million - $5.74 Million
468,446 Added 331.48%
609,765 $2.12 Million
Q1 2022

May 13, 2022

SELL
$9.54 - $14.26 $479,795 - $717,178
-50,293 Reduced 26.25%
141,319 $1.6 Million
Q4 2021

Feb 14, 2022

BUY
$7.34 - $10.25 $1.41 Million - $1.96 Million
191,612 New
191,612 $1.83 Million
Q2 2021

Aug 16, 2021

SELL
$11.76 - $16.85 $290,377 - $416,060
-24,692 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$14.21 - $25.3 $781,152 - $1.39 Million
-54,972 Reduced 69.0%
24,692 $393,000
Q4 2020

Feb 16, 2021

BUY
$14.8 - $20.37 $518,310 - $713,377
35,021 Added 78.45%
79,664 $1.22 Million
Q3 2020

Nov 16, 2020

SELL
$11.74 - $22.0 $549,150 - $1.03 Million
-46,776 Reduced 51.17%
44,643 $829,000
Q2 2020

Aug 14, 2020

BUY
$5.67 - $15.86 $454,269 - $1.27 Million
80,118 Added 708.95%
91,419 $1.11 Million
Q3 2019

Nov 14, 2019

BUY
$10.0 - $17.01 $113,010 - $192,230
11,301 New
11,301 $114,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $30.6M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.